Diametric Capital LP Has $1.38 Million Stock Holdings in ASP Isotopes Inc. (NASDAQ:ASPI)

Diametric Capital LP raised its holdings in ASP Isotopes Inc. (NASDAQ:ASPI) by 4.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 303,855 shares of the company’s stock after buying an additional 11,886 shares during the quarter. ASP Isotopes accounts for about 0.9% of Diametric Capital LP’s investment portfolio, making the stock its 21st largest position. Diametric Capital LP’s holdings in ASP Isotopes were worth $1,376,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ASPI. Philadelphia Financial Management of San Francisco LLC grew its stake in shares of ASP Isotopes by 158.3% in the third quarter. Philadelphia Financial Management of San Francisco LLC now owns 991,863 shares of the company’s stock worth $2,757,000 after acquiring an additional 607,893 shares during the last quarter. Geode Capital Management LLC boosted its holdings in ASP Isotopes by 42.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,118,423 shares of the company’s stock valued at $3,110,000 after purchasing an additional 334,836 shares during the period. Rovida Investment Management Ltd acquired a new stake in ASP Isotopes in the 4th quarter worth $990,000. Walleye Capital LLC acquired a new stake in ASP Isotopes in the 3rd quarter worth $536,000. Finally, JPMorgan Chase & Co. raised its position in shares of ASP Isotopes by 854.6% during the fourth quarter. JPMorgan Chase & Co. now owns 211,893 shares of the company’s stock valued at $960,000 after buying an additional 189,697 shares during the last quarter. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Stock Up 12.2 %

NASDAQ ASPI opened at $4.69 on Tuesday. ASP Isotopes Inc. has a twelve month low of $1.86 and a twelve month high of $9.33. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. The stock has a market cap of $334.82 million, a PE ratio of -7.69 and a beta of 3.66. The firm has a 50-day simple moving average of $4.99 and a 200 day simple moving average of $4.95.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.